300583.SZ(300583.SZ)
300583.SZ
$13.77—Stale · unknown old
SHZ • Last print unknown ago
$13.77—Stale · unknown old
Shandong Sito Bio-technology Co., Ltd. specializes in the development and production of bio-pharmaceutical products, primarily focusing on biopharmaceuticals and health supplements. The company operates mainly in China, leveraging its proprietary technologies in fermentation and extraction processes to differentiate its product offerings in a competitive market.
Shandong Sito generates revenue through the sale of biopharmaceutical products and health supplements, utilizing proprietary fermentation technologies that enhance product efficacy. The company benefits from a growing demand for health supplements in China, driven by increasing health awareness among consumers.
Changes in regulatory approvals for new biopharmaceutical products
Market demand fluctuations for health supplements in China
Raw material price volatility affecting production costs
Partnerships or collaborations with larger pharmaceutical firms
Regulatory changes impacting the approval process for biopharmaceuticals
Technological disruption from new entrants in the biotechnology space
Intense competition from established pharmaceutical companies
Emerging biotech firms with innovative products
Negative net margin indicating potential cash flow issues
Moderate debt levels could constrain financial flexibility
moderate - The company is somewhat sensitive to economic cycles as consumer spending on health products can fluctuate with economic conditions.
The company has a moderate sensitivity to interest rates as rising rates can increase financing costs for R&D and expansion, impacting profitability.
minimal - The company's debt levels are manageable, and it does not heavily rely on credit for operations.
growth - Investors looking for exposure to the expanding health supplement and biopharmaceutical markets in China.
high - The stock has shown significant volatility, particularly with a 40.3% decline over the past year.